Blog Posts

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, ROCHE, NOVARTIS

Jul 22, 2022

Big Pharma Kicks Off Q2 Earnings Calls After More than 100 Price Hikes to Read More

SECOND OPINION: BIG PHARMA’S PRICE HIKES HAVE LONG OUTPACED INFLATION

Jul 11, 2022

PhRMA Ads Falsely Claim the Industry’s Egregious Pricing Practices Don’t Read More

BIG PHARMA WATCH: ABBVIE UTILIZED LOOPHOLES TO AVOID PAYING BILLIONS IN U.S. TAXES & FURTHER MAXIMIZE PROFITS WHILE HIKING PRICES

Jul 8, 2022

Committee Report Shows How Brand Name Drug Company Further Juiced Profits on Read More

DOSE OF REALITY: PATENT HEARINGS OFFER OPPORTUNITY TO HOLD BIG PHARMA ACCOUNTABLE FOR ANTI-COMPETITIVE PRACTICES

Jun 22, 2022

Lawmakers Can Highlight Tactics Designed to Block More Affordable Alternatives Read More

SECOND OPINION: PHRMA REDUXES DEBUNKED BLAME GAME RHETORIC IN NEW AD CAMPAIGN

Jun 17, 2022

Big Pharma Trots Out Tired, Dishonest Arguments Designed to Evade Read More

THEY SAID IT! ANTITRUST EXPERTS AND OFFICIALS SHINE A LIGHT ON BIG PHARMA’S ANTI-COMPETITIVE PLAYBOOK

Jun 16, 2022

Federal Trade Commission Workshop Highlights How Brand Name Drug Companies Read More

BIG PHARMA WATCH: PHARMACEUTICAL COMPANIES HIKED LAUNCH PRICES BY 20 PERCENT EVERY YEAR FOR 14 YEARS

Jun 9, 2022

Nearly Half of All New Brand Name Drugs Cost More Than $150,000 Per Year In Read More

BIG PHARMA WATCH: REPORTS SHOW BIG PHARMA HAD ANOTHER BANNER YEAR IN 2021

Jun 3, 2022

Brand Name Drug Companies Posted Massive Profit Growth and Invested Heavily in Read More

BIG PHARMA WATCH: STUDY FINDS BIG PHARMA TARGETS MOST PROFITABLE DRUGS FOR NEW FORMULATIONS TO BLOCK COMPETITION

May 25, 2022

Brand Name Drug Companies Four Times as Likely to Reformulate Blockbuster Read More

BIG PHARMA WATCH: NEW ANALYSIS FINDS BIG PHARMA REAPS BIG MULTIPLES FROM MEDICARE SPENDING ON TOP DRUGS

May 13, 2022

Part D Spending on 10 Most Popular Medications Over Five Years Averages Five Read More

BIG PHARMA EARNINGS WATCH: BRISTOL-MYERS SQUIBB, ABBVIE, ASTRAZENECA AND PFIZER

May 6, 2022

Another Round of Big Pharma Giants Beat Wall Street Expectations In Q1 After Read More